Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

NCT01094886 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis
Osteoarthritis, Knee
Osteoarthritis, Hip
Thromboembolism

Interventions

DRUG: Rivaroxaban

Sponsor

Ortho-McNeil Janssen Scientific Affairs, LLC

Collaborators

[object Object]